This initiative is a global partnership that brings together pharmaceutical companies, governments, international organizations, and patient groups to address the growing burden of non-communicable diseases (NCDs) in low- and middle-income countries. Access Accelerated aims to improve access to prevention, diagnosis, and treatment of NCDs.